Prevention can lead to the rejection of a cancer diagnosis

Published Date: 13 Mar 2023

Some adults do not consider the importance of testing, while others believe that a healthy diet with regular bowel movements does not require testing, according to the study.

Read Full News

Latest News

Masson Tumor in a Young Woman Mimicking Angiosarcoma

An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.

Healthcare Strikes Ethical in Few Cases: Ethicist

Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.

Time to Relabel Low-Risk Prostate Cancer as Precancerous?

A new modeling study suggests it is time, though outside experts were split on the idea.

FDA Psychiatry Roundup: May 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

Could a Urine Test Accurately Diagnose Autism?

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically developing peers. However, larger studies are needed to validate the approach.

NICE Clears New Drug for Platinum-Resistant Ovarian Cancer

NICE has recommended mirvetuximab soravtansine for resistant ovarian cancer, citing better survival and a less burdensome treatment experience.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision and histopathologic diagnosis essential.

Ethicist Art Caplan discusses the ethics of healthcare strikes for patients and workers.

A new modeling study suggests it is time, though outside experts were split on the idea.

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically developing peers. However, larger studies are needed to validate the approach.

NICE has recommended mirvetuximab soravtansine for resistant ovarian cancer, citing better survival and a less burdensome treatment experience.

News All Time

RAS Drug Nearly Doubles Survival in Mets Pancreatic Cancer

In a 500-patient phase 3 trial, daraxonrasib extends median overall survival to 13.2 vs 6.7 months for chemotherapy in second-line metastatic pancreatic cancer.

NHS Failing Frail Patients as GPs Overwhelmed by Targets

GPs assessed just 17% of older patients for frailty in 2024-25, well below the 100% required by their contract, MPs warn.

Nurses Could Be the Key to Better Self-Care for IBD Patients

A nurse-patient ‘mutuality’ shows a positive association with self-care behaviors in adults with inflammatory bowel disease.

Fulcrum Scraps Sickle Cell Drug Program After FDA Raises Cancer-risk Concerns

Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug ⁠after the U.S. Food and Drug Administration raised cancer-risk...

Incidental Splenomegaly: Which Findings Raise Concern?

Incidental splenomegaly detected on imaging may warrant closer evaluation because malignancy and cirrhosis risk increase with splenic size.

Early UC Intervention: Tips for Better Outcomes

Dr Adam Faye discusses best practices for early interventions in ulcerative colitis care.

Defecation Urgency in IBS Reframed as a Brain-Gut Phenomenon

Although the sensation of defecation urgency in patients with IBS appears in the gut, a recent study suggests that it’s nuanced and related to several regions of the brain.

What a Baby’s Laughter Reveals About the Developing Brain

Experts say an infant’s laughter is an important developmental marker, offering a window into brain development and a child’s emerging social world.

Fecal Transplant Curbs Alcohol Cravings

A single fecal microbiota transplantation improved alcohol abstinence and reduced relapse rates in patients with alcohol-associated cirrhosis and alcohol use disorder.

Swallowed Microrobots: Is GI Treatment Entering a New Era?

Swallowed microrobots are moving targeted GI drug delivery and minimally invasive biopsies closer to clinical reality, with researchers exploring new ways to improve precision therapy.

What Is Canada Doing About Rising Maternal Mortality?

Without a robust national surveillance system and confidential reporting, it’s impossible to know where Canada stands on maternal mortality.

Beating the Bloat: Key Strategies for Diagnosis, Treatment

Experts discuss diagnosis, diet, medications, and individualized management strategies for abdominal bloating.

Vitamin B6 Deficiency Can Signal Poor Liver Disease Outcomes

Vitamin B6 deficiency is linked to an increased risk for liver transplantation and hepatic decompensation across different populations with primary sclerosing cholangitis.

How PCPs Can Support Menopausal Women With Weight Gain

Weight gain in menopause may be frustrating for patients, but there are ways to help them fight it, and to understand it.

May 29 2026 This Week in Cardiology

A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in cardiac amyloidosis, and a lipid guideline rebuttal are the topics John Mandrola, MD, discusses in this week’s podcast.

Man Suffers Vagal Bradycardia After Abdominal Trauma

After a baseball collision, a 51-year-old man presents with bradycardia that progresses to shock; imaging finds a large mesenteric hematoma that requires atropine and urgent surgery.

Recommended News For You

New study highlights success of financial toxicity tumor board in reducing cancer treatment costs

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

How Do Younger People Fare With Stool Tests for CRC Screening?

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

Higher Binge Drinking Rates Linked to New Cannabis Laws.

FDA Approves CAR-T Product Use for Myeloma Early.

Recommended Articles For You

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies 

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells 

The Latest Research on Wiskott Aldrich Syndrome  

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis

2.

a brand-new generic therapy for different types of cancer.

3.

Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?

4.

Implant-based reconstruction linked to increased risk of breast lymphomas

5.

Prior authorizations draining time, energy from many cancer patients

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians

3.

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends

4.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

5.

The importance of understanding normal serum osmolality

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot